TGF-β indirectly favors the development of human Th17 cells by inhibiting Th1 cells

136Citations
Citations of this article
97Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Human Th17 clones and circulating Th17 cells showed lower susceptibility to the antiproliferative effect of TGF-β than Th1 and Th2 clones or circulating Th1-oriented T cells, respectively. Accordingly, human Th17 cells exhibited lower expression of clusterin, and higher Bcl-2 expression and reduced apoptosis in the presence of TGF-β, in comparison with Th1 cells. Umbilical cord blood naïve CD161+CD4+ T cells, which contain the precursors of human Th17 cells, differentiated into IL-17A-producing cells only in response to IL-1β plus IL-23, even in serum-free cultures. TGF-β had no effect on constitutive RORγt expression by umbilical cord blood CD161+ T cells but it increased the relative proportions of CD161+ T cells differentiating into Th17 cells in response to IL-1β plus IL-23, whereas under the same conditions it inhibited both T-bet expression and Th1 development. These data suggest that TGF-β is not critical for the differentiation of human Th17 cells, but indirectly favors their expansion because Th17 cells are poorly susceptible to its suppressive effects. © 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Author supplied keywords

Cite

CITATION STYLE

APA

Santarlasci, V., Maggi, L., Capone, M., Frosali, F., Querci, V., De Palma, R., … Annunziato, F. (2009). TGF-β indirectly favors the development of human Th17 cells by inhibiting Th1 cells. European Journal of Immunology, 39(1), 207–215. https://doi.org/10.1002/eji.200838748

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free